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A Randomized Double Blind Placebo Controlled Trial of 
the Effect of Amiodarone Compared to Placebo Before, 
During, and After Electrical Cardioversion for Persistent 
Atrial Fibrillation 
Kevin S. Charmer. Andrew Birchall, Richard P. Steeds, Yorkshire Cardiology 
Collaborative Research Group, Royal Hallamshirs Hospital, Sheffield, United Kingdom 
Background: Cardioversion (DCCV) of persistent atrial fibrillation (AF) to sinus rhythm 
(SR) improves symptoms. exercise tolerance and vsntricular function. The efficacy of 
DCCV is limited by a high relapse rate within 3 months. Prophylactic treatment with ami- 
odarons may increase success but previous randomised studies have lacked a placebo 
control. This was a randomised double blind comparison of oral amiodarone 400mg BD 
for 2 weeks prior to and POOmg OD for 8 weeks following DCCV with placebo. 
Methods: Subjects with persistent AF aged >18 years stable on anticoagulant therapy 
for more than 2 weeks were randomised. Subjects were reviewed at 1, 4, and 8 weeks 
post-DCCV. 
Results: 172 subjects were enrolled but 4 were withdrawn due to protocol violations and 
7 withdrew consent. There were no significant differences in baseline characteristics 
between those on amiodarone (123) and those on placebo (38) -randomization was dis- 
proportionate as this was a powered, intended sub-study of a larger trial. Reversion to 
SR occurred before elective DCCV in 26 out of 123 (21%) subjects on amiodarone but 
none on placebo (p=O.O02). In the remaining 135 subjects, there was no difference in the 
success rate of DCCV (70/97 (72%) amiodarone v 30/38 (79%) placebo). There was no 
difference in the energy required to obtain SR (mean number of shocks: amiodarone 2.3 
+ 1 “placebo 2.5 + I; total energy: amiodarone 296+ 36 J v placebo 381 + 70 J). At 8 
wseks, 33 (35%) patients who were taking amiodarone had first recurrences of AF com- 
pared to 24 (80%) on placebo (pcO.001). There was an increase in the number of sub- 
jects requiring changes in warfarfn dose following the introduction of amiodarone (83 
(67%)) compared with placebo (8 (21%). p<O.OOl)) but no difference in ths number of 
adverse events over the 8 week follow-up period. 
Conclusion : Pre-treatment with amiodarone has the advantage of chemical CV in a sig- 
nificant number of patients without the need for subsequent DCCV under general anes- 
thesia. Pre-treatment does not alter the efficacy of electrical DCCV or the energy 
required for restoration of SR. Amiodarone is more effective than placebo in the preser- 
vation of SR at 8 weeks following successful CV for AF without an increase in complica- 
tions. 
1089-10 Recurrence Rate of Atrial Fibrillation in Patients After 
the First Relapse: A Comparison Between Metoprolol 
CR/XL, Sotalol, and Amiodarone 
Karlheinz Seidl, Margit Vatsr, Monika Rameken, Andreas Brandt, Axe1 Droegemueller, 
Jochen Senges, Hearl Center, Ludwigshafen, Germany 
Between 01197 and 08102, 517 patients (pts) after their first recurrence of atrial fibrillation 
(AF) were treated either with metoprolol CR/XL (M, 47 mg - 190 mg/die), sotalol (S, 160 
mg - 320 mgldie) or amiodarone (A, maintaining dose 200 mgidie) for the first time as 
long-term therapy after successful electrical cardioversion. Follow up was performed in 
all pts for symptomatic recurrence of AF. 
Results: Age (62 * 11 (M) vs 63 f 11 (S) YS 62 t IO (A) years), frequency of male sex 
(72% vs 74% vs 67%). left atrial diameter (44 f 6 vs 44 * 6 vs 45 + 5) and frequency of 
organic heart disease (58% vs 55% YS 62%) were comparable between all groups. Dur- 
ing follow up of 3 years 94/161 (58%) treated with M and 163/228 pts (71%) treated with 
Sand 1271182 pts (70%) treated with A suffered from symptomatic recurrence of AF. In a 
multiple logistic regression model pts treated with M had a significant better outcome 
than pts treated with S or A in maintaining sinus rhythm (OR = 0.6, 95% Cl 0.35 - 0.89, p 
= 0.013), adjusted for age > 70 years, gender, left atrial diameter > 45 mm, organic healt 
disease. Conclusion: During a mean follow up of about 3 years pts treated with M had a 
better outcome than pts with S or A in maintaining sinus rhythm after successful electrical 
cardioversion of AF. About 40% of pts treated with M were free of symptomatic recur- 
rence of AF. Pts treated with M had a higher compliance than pts treated with S or A. 
Metoprolol CW sotalol amiodarone 
XL 
” 161 pts 228 pts 128 pts 
recurrence 94/161 pts 163/228 pts 127/l 62 pts 
(58%) (71%) (70%) 
compliance 92% 85% 76% 
follow up (mean +/-SD, 966 +I- 451 981 +/- 412 889 +/- 436 
days) 
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1089-l 1 Oral Bolus of IC Antiarrhythmic Drugs for Atrial 
Fibrillation: Outpatient Versus Inpatient Administration 
Nassir F. Marrouche, Johannes Brachmann, Jens Guenther, Volker Schibgilla, Walid 
Saliba. GeN Tomassoni, Salwa Beheiw. Ennio Pisano. Dianna Bash, The Cleveland 
Clinic Foundation, Cleveland, OH, Klinikum Coburg, Coburg, Germany 
We prospectively assessed the safety of outpatient versus inpatient administration of a 
large oral dose of either Propafenone (P) or flecainide (F) combined with metoprolol or 
diltiazem. A total of 6O+l mg of P or 300 mg of F were given with 25-50 mg of Metoprolol 
or 240 mg of diltiazem slow release. Patients were randomized to inpatient administra- 
tion under monitored conditions or outpatient administration. A total of 107 patients were 
enrolled in 5 institutions. Fifty-six patients were assigned to inpatient and 61 patients to 
outpatient administration of drugs. 
Termination was achieved in 34 out of 56 (61%) inpatient and in 45 out of the 61 (73%) 
outpatient subjects. None of the patients had syncope. Two patients on F experienced 
near syncope before temlinaiion of AF. Sustained rates faster than 150 bpm were seen 
in 4 patients, all on F. Symptomatic Bradycardia before or after terminatiomof AF was not 
observed. Transient side effects not requiring discontinuation of therapy was reported by 
73 patients (63%). These included metallic taste (45 pts), gastric discomfort (23 pts), diz- 
ziness (3 pts), and tremor (2 pts). Drugs wers discontinued in 1 outpatient, and 1 inpa- 
tient subjects. In 2 outpatients, and 1 inpatient subjects Metoprolol and diltiazem were 
increased to achieve better rate control. 
In conclusion, outpatient initiation of a large oral bolus of IC drug combined with rate con- 
trol drugs appeared as safe as inpatient initiation. 
1089-12 Which Right Atrial Site Is Better for Burst 
Overstimulation of Acute Atrial Fibrillation and Atypical 
Atrial Flutter? 
Nikolav Shlevkov, Alexander Yang. Rainer Schimpf. Helga Bislik, Jan Schrickel, 
Alexander Bitzen. Jiirg 0. Schwab, Berndt Ltidsritz, Thorsten Lewalter, University of 
Bonn, Bonn, Germany 
Aim: To compare prospectively the efficacy of 20-Hz burst pacing at Iwo defined right 
atrial sites with a “no pacing” strategy in the termination of acute atrial fibrillation (AF) or 
atypical atrial flutter (AAFL). Methods: In 76 consecutive patients (pts) (52*14 years, 50 
male) a total of 87 episodes of sustained (r2 min) spontaneous or induced acute AF 
(n=51) or AAFL (n=36) occurred during electrophysiologic study. AF and AAFL were 
defined by polymorphic and monomorphic endowdial activity with cycle lengths ~210 
ms, respectively. The pts were randomised to 3 treatment strategies: (1) pacing at the 
right atrial appendage (RAA) using up to IO consecutive 20-Hz burst trains (duration of 
each train: 3 s. interval between two trains: 15 s) followed bv oacino at the coronaw sinus ,. _ 
ostium (CS-OS) in case of AF/AFFL persistence: (2) pacing at the CS-OS using the same 
oacmo technioue followed bv burst oacino at RAA or 131 observation of AFiAFFL for 6 
Ain. Results: burst pacing a;the C&OS las associate; with a significantly higher AAFL 
conversion rate than both RAA pacing (~~0.03) and the observation strategy (p<O.OOl). 
whereas there was no difference between the 3 strategies in regard to AF termination 
(Figure 1). Conclusion: Burst pacing (20-Hz) at the CS-OS was successful in 85 % of the 
AAFL pts and demonstrated to be significantly superior to RAA-pacing or the observation 
strategy. This finding may be of relevance for pts undergoing implantation of a pace- 
maker capable of atrial burst pacing. 
1089-13 Mechanisms Responsible for the Initiation and 
Maintenance of Atrial Fibrillation Assessed by 
Noncontact Endocardial Mapping System 
Seunq Woon Rha, Young-Hoon Kim, Sang Weon Park, Cheol Ung Choi, Seong Mi Park, 
Wan Joo Shim, Young Moo Ro, Korea University Medical Center. Seoul, South Korea 
Background:.We undertook this study to assess whether a single reentry or focal activ- 
ity is important in the initiation and maintenance of atrial fibrillation (AF) and their relation- 
ship with underlying anatomical struc1ures using a non-contact mapping system in 
patients with AF. 
Method: 20 patients(r6 men, mean age 52, range 25-68 years) with paroxysmal AF 
(n=l8) and persistent AF (n=2) underwent lefl atrial mapping. A multielectrode array 
(Ensite 3000) and a conventional ablation catheter were advanced into the left atrium 
(LA) following double transseptal punctures. Activation sequences of atrial premature 
contraction (APC) which triggered AF or drove AF to maintain were mapped. The relation 
between the activation panern during spontaneous AF or induced AF after internal car- 
dioversion using direct current and underlying anatomical structures were identified. 
Results: During AF. maximal number of wavelets were 3 in 65% (11/17) of patients, and 
2 in 35% (6/17) and the mean number of wavelets was 1.4. 2 different mechanisms 
responsible for the initiation and maintenance of AF were observed: 1) Focally triggered 
JACC March 19,2003 ABSTRACTS - Cardiac Arrhythmias 99A 
AF was shown in 78% (14/18): APC only Initiated AF, not involved in the maintenance of 
AF. Triggering AF by APC was related to wave break-up at the septopulmonary bundle 
near the RSPV ostium in 55% (lO/ZO), posterior roof of LA in 35% (7120). 2) Focally 
driven AF was shown in 22% (4/18): APCs not only initiated AF but also played a role in 
the maintenance of AF. During AF, these APCs were continuously generated from the 
arrhythmogenic foci and activated the LA. The wave propagation patterns of induced AF 
were different from those of spontaneous AF in 54.5% of patients. APC originated from 
single PV was in 45% (g/20), two PVs 15% (3/20) and more than three PVs 20% (4120). 
Non-PV foci were identified in 37.5% (6116) of the patients and mostly located at the pos- 
terior roof of the LA (12.5%, 2/16). 
Conclusion: A non-contact mapping system may facilitate identification of the mecha- 
nwns and the relationship with the underlying anatomvzzal structures responsible for the 
initiation and maintenance of AF. 
1089-14 C-Reactive Protein in Atrial Fibrillation: Evidence for the 
Presence of Inflammation in the Genesis and 
Perpetuation of the Arrhythmia 
Monica Acevedo, Ramon L. Corbalan. LUIS Perez, Sandra Braun, Jaime Pereira, Teresa 
Lira, Carlos Navarrete, Catholic University Hospital, Santiago, Chile 
Background: Atrial fibrillation (AF) is associated to a number of clinlcal entities with an 
underlying acute or chronic inflammatory process. It is possible that inflammation could 
contribute to the initiation and perpetuation of this arrhythmia. 
Alms: To evaluate the presence of an inflammatory process in patients with newly diag- 
nosed non valvular AF. 
Methods: We studied 109 consecutive patients admitted for newly diagnosed AF. Forty 
patients resulted in chronic AF and 69 had paroxysmal AF. All patients had determina- 
tions of C reactive protein (CRP) at basellne and at 30 days, 68 had CRP at 1 year of fol- 
low-up. In addition the patients were evaluated clinically and with general laboratory 
tests. A transesophageal echocardiogram (TEE) was performed withln the first 24 hours 
of admission to evaluate left atrial and ventricular dimensions, LV funcbon and the pres- 
ence of spontaneous echo contrast or intracavitary thrombus. 
Results: Mean age was 67 -t 14 years and 50% were z-70 years. Hypertension was found 
I” 57%, diabetes I” 17% and cardiomyopathy in 36% of cases. A history of previous sys- 
temlc embolism was present in 6 patients. Relevant TEE findings were left atrial diameter 
>45 mm in 52%, left ventricular dysfunction in 15% and the presence of spontaneous 
echo contrast and or LA thrombus I” 53% of cases. CRP levels in the whole group were 
l.O*l.E mg/dl, 0.9k1.4 mg/dl I” patients with paroxysmal AF and I.12 2.4 mgidl in 
patients with chronic AF (p=O.OOl AF group, p=O.Ol paroxysmal AF group and p=O.Ol 
chronic AF group vs 20 normal sublects in sinus rhythm). CRP levels correlated with 
other laboratory markers of inflammation (VHS, p=O.O03 and WBC, p= 0.004) and with 
the presence of LV dysfunction in TEE (p = 0.02) in multivariate analysis. At 30 days 
there was a significant decrease in CRP both I” chronic and paroxysmal AF ( p= 0.048 
and 0.03 respectwely). At 1 year of follow up mean CRP levels in patients that were still 
in AF were 1 .&I .8 mg/dL, whereas in those with sinus rhythm were 0.5iO.5 mg/dL, p = 
0.048) 
Conclusion: This study prowdes evidence for the presence of an inflammatory process in 
patlents with newly diagnosed non valvular AF. The perslstence of inflammation is asso- 
ciated with chronic AF at 1 year of follow up. 
1089-15 Plasma Amino-Terminal Pro-B-Type Natriuretic Peptide 
Predicts Postcardioversion Reversion to Atrial 
Fibrillation 
A. Mark Richards, John G. Lainchbury, Richard W. Troughton. Gary Nicholls, Chris M 
Frampton. Timothv G. Yandle. Christchurch Cardloendocrw Research Group. 
Christchurch, New Zealand 
Background: With mounting evidence that rate control plus anticoagulation IS the treat- 
ment of choice for chronic atrial fibrillation (AF), there is a need to improve patient selec- 
tion for electrical cardioversion (CV) from AF by more accurate predlctlon of those likely 
to exhibit sustained return to sinus rhythm. 
Methods: Plasma cardiac natriuretic peptides (NPs, including ANP. BNP and pro-amino- 
terminal BNP [N-BNP]) and adrenomedullin (ADM) were assayed before, immediately 
after and six weeks aftdrcardioversion in 151 patients with chronic AF. 
Results: Plasma NPs (but not ADM) fell significantly immediately postsuccessful CV (all 
pcO.0001) but not in 15 patients in which CV failed. At SIX months postCV, 65 patients 
remained in sinus rhythm whilst 86 were in AF. Plasma NPs (but not ADM) were signifi- 
cantly higher at all three sampling times in those destined to be in AF at six months. 
Kaplan-Meier analysis indicated significant separation of AF-free suwival curves by 
median preCV and immediate postCV levels of BNP (p=O.O39 and 0.0024 respectively) 
and N-BNP (p=O.O22 and 0.010) but not ANP (p=O.O75 and 0.063) or ADM (p=O.425 and 
0.253). Tertiles of precardioversion N-BNP differed slgmficantly for risk of AF at SIX 
months (39, 60 and 70% risk in frst, second and third tertiles respectively; p=O.O06). Mul- 
tiple regression analysis indicated both pre and immediate postcardioversion levels of 
BNP (p=O.Ol and 0.009) and N-BNP (p=O.O06 and 0.011) were predictive of reversion to 
AF independent of age, left ventricular function or the prophylactic prescription of beta 
blocketslamiodarone. 
Conclusions: In patients with chronic AF, those with plasma N-BNP concentrations ele- 
vated above the lowest tertile may be more rationally treated with rate control and antico- 
agulation rather than undergoing single or serial electrlcal cardwersion. 
1089-18 C-Reactive Protein and Microalbuminuria Are 
Associated With Atrial Fibrillation 
Folkert W. Asselberqs Gilles F. Diercks. Maarten P. van den Berg, Ad J. van Boven, 
lsabelle C. van Gelder, Dirk J. van Veldhuisen. Wiek H. van Gilst, University of 
Groningen, Groningen. The Netherlands, University Hospital Groningen, Groningen, The 
Netherlands 
Background: Atrial flbrlllation (AF) is a major risk factor for stroke and cardiac events. 
Early identification of subjects at risk for AF might help to prevent the onset of AF. The 
inflammatory marker C-reactive protein (CRP) and mwoalbuminuria are easy to obtain 
risk indicators for ischemic heart disease. lschemlc heart disease is one of the most 
important predisposing factor for AF. In this study, we hypothesized that CRP and 
microalbuminuria are associated with AF. 
Methods: In a large population based survey (8501 subjects), atrial fibrillation was mea- 
sured by one 12 lead electrocardiogram and defined according to Minnesota codes 8.3.1 
and 8.3.3. Mean age was 49 + 12.7 years and 49.8% male. Microalbuminuria was 
defined as 30-300 mgi24h. High sensitive CRP was dichotomized (three lowest quartile, 
CRP< 2.97 mg/l versus the highest quartile, CRP, 2.97 mg/l). The following cardiovascu- 
lar risk factors were assessed and used in the analysis: age, sex, hypertension, hyperc- 
holesterolemia, obesity, diabetes mellitus, smoking, ischemic heart disease, and left 
ventricular hypertrophy. 
Results: Atrial fibrillation was present in 75 (0.9 %) subjects. AF was significantly associ- 
ated with the highest quartile of CRP (2.63 [1.71-4.051, p-zO.001) and microalbuminuria 
(3.46 [2.18-5.491, pcO.001). When all cardiovascular risk factors were entered simulta- 
neously, CRP (2.09 [1.29-3.401. p=O.O03) and microalbuminurla (2.08 [I .21-3.501, 
p=O.OOE) remained significantly associated with AF. The combination of the highest quar- 
tile of CRP and the presence of microalbuminuria showed a higher association with AF 
(7.36 [4.16-13.01], pcO.OOl), even after adjusting for all cardiovascular risk factors (4.07 
[2.08-7.951, p<O.OOl). 
Conclusion: In this study, we demonstrated that C-reactwe protein, microalbuminuria, 
and the combination of both are associated with atrium ffbrillation independent of cardio- 
vascular risk factors. 
1089-17 Is Atrial Fibrillation an Inflammatory Disease Reflected 
by Elevated C-Reactive Protein? 
Chloe A. Allen Mavccxk Donald L. LappB, Brian G. Crandall, Joseph 8. Muhlestein, 
Benjamin D. Home, Tami L. Bair, Qunyu Li, Sandra P. Reyna, Dale G. Renlund, Jeffrey 
L. Anderson, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Background Inflammation is implicated in the pathogenesis of cardiovascular diseases. 
C-reactive protein (CRP), a marker of systemic inflammation, predicts increased risk of 
coronary events and stroke. Atrial fibrillation (AF) is associated with cardiac structural 
changes, including atrial fibrosis, which may have an inflammatory basis. In a recent 
small retrospective study, patients (pts) with AF had higher CRP levels than controls. We 
prospectively tested the hypothesis that CRP is a risk factor for AF in a large cohort. 
Methods Consecutive pts (Nc3.357) free from myocardial infarction had a CRP level 
drawn at the time of angiography. These pts were enrolled in the Registry of the Inter- 
mountain Heart Collaborative Study between 1994-2001. Those with 21 ECG showing 
AF during the study period formed the disease group (1x347). Those with neither ECG 
nor clinical (ICD-9) evidence for AF comprised the control (C) group (n=2449). The other 
561 were excluded. CRP was measured by fluorescence polarization immunoassay 
(Abbott). Logistic regression assessed quartile (Q) of CRP and 13 other clinical and 
angiographic variables as predictors of AF. 
Results Average age was 63+12 years; 33% were women; 61% had significant core- 
nary artery disease (CAD), and 26%. no CAD; median CRP was 1.21 mg/dL. AF pts 
were older (by 7 years) and more frequently had a history of heart fatlure (HF) than C pts 
(41% vs. 10%) (both p<O.OOl). CRP was higher in AF than C pts (1.97 vs. 1.51 mg/dL, 
p<O.OOl). Q-CRP was a univariable predictor of AF (odds ratio [OR]=l.39/Q, Cl 1.25. 
1.55, p<O.OOl). After adjustmg for age and HF, the predictive value of Q-CRP was 
reduced but retained significance (OR=l.ZO/Q, Cl 1.07-I .34, p=O.OOZ). Further adjusting 
for 11 other variables had little effect (OR=1 .19/Q. CI=l.O6-1.33, p=O.O03) 
Conclusion: Increasing CRP independently predicted an Increased risk of AF among a 
large, prospectively studied patient cohort assessed anglographically. These results sup- 
port the proposal that AF pathophysiology includes an inflammatory mechanism. that ele- 
vated CRP is a new risk marker for AF propensity, and that AF therapies targeting 
inflammation are worthy of testing. 
1089-18 Altered Collagen Subpopulations and the Matrix 
Metalloproteinase Regulation in the Development of 
Atrial Fibrillation in Atrial Dysfunction 
Jun Guanggen Cui, Fardad Esmailian, Mark Plunkett, Daniel Marelli, Abbas Ardehali, 
Jonah Odim, Hillel Laks, Luyi Sen, UCLA Medical Center/UCLA School of Medicine, Los 
Angeles, CA 
BackgroundMyocardial remodeling has been found not only in ventricle. but also in 
atrium in dilated cardiomyopathy and heart failure. We hypothesize that atrlal extracellu- 
lar matw remodeling may be responsible for the AFib recurrence and maintenance in 
atria1 dysfunction. 
Methods and Results Tissue samples from 55 hearts explanted from patients with 
dilated cardiomyopathy and end-stage heart failure underwent heart transplantation were 
examined. Nineteen patients had permanent AFib (PmAF), 20 had persistent AFlb 
(PsAF) and 16 had no documented AFib (NAF). Sixteen donor leff atrium were used as 
normal control (CN). Fibrillar collagen subtype I and III distributions in the left atrium (LA) 
were exammed by lmmunofluoresent staining. LA metalloproteinase-1 and 2 (MMP-I. 
MMP-P), tissue inhibitor of metalloproteinase-1 and 2 (TIMP-I, TIMP-2) proteins were 
evaluated by western blot. Type I collagen volume fraction (CVF-I) increased significantly 
